Sam Burer, professor of business analytics in the Tippie College of Business, was the recipient of the 2020 INFORMS Computing Society prize for his pioneering work on low-rank semi-definite programming. The prize is an annual award for the best English language paper or group of related papers dealing with the Operations Research/Computer Science interface.
The development of a COVID-19 vaccine is at the forefront of everyone’s minds. Recent news suggests that a solution may be available in 2021, though the hope is sooner. The race for a vaccine adds to a body of evidence that suggests when under pressure the pharmaceutical industry reacts quickly.
When it comes to COVID-19, what happens in Vegas doesn’t stay in Vegas. Las Vegas casinos reopened June 4, and they have become a likely hotbed for the spread of the novel coronavirus, public health experts said. But if tourists return home and then test positive for COVID-19, the limitations of contact tracing in the midst of a pandemic make it unlikely such an outbreak would be identified.
A vaccine for the coronavirus that causes covid-19 appears to be our best strategy to ending the current pandemic. Unfortunately, the fastest time frame in which scientists have managed to create any vaccine in history was four years, and there’s already plenty of skepticism surrounding the safety, availability, and effectiveness of any future covid-19 inoculation. So let’s go over the most pressing questions.
Thank you very much for the excellent article, “Get your flu shot!” Aug. 16, page A1, with the interview with Dr. Mark Kenton, who is urging that we get a flu shot this year, due to the Covid-19 pandemic. I agree that this is imperative not only for our community’s health but also to try to limit the demands for healthcare resources during what will certainly be very challenging fall and winter seasons with students returning to our towns and with still many unknowns about the coronavirus.
Ashley Smith
Public Affairs Coordinator
INFORMS
Catonsville, MD
[email protected]
443-757-3578
An audio journey of how data and analytics save lives, save money and solve problems.
Cutting-edge chips, especially those designed to power emerging AI applications, tend to receive the most attention in the media and generate the most excitement. However, so-called “legacy” chips are just as important — if not more — to our daily lives.
A number of startups and cloud service providers are starting to offer tools for monitoring, evaluating, and correcting problems with generative AI in the hope of eliminating errors, hallucinations, and other systemic problems associated with this technology.
Tariffs could raise the cost of medical care and prescription drugs for people in the U.S.
New findings from a team of renowned researchers calls for transparency and rigorous oversight of the U.S. Medicare Advantage (MA) program, the United States' largest healthcare capitation program.
Dockworkers on the East and Gulf coasts could go on strike again in less than two weeks if they don’t reach a contract agreement with ports and shippers. Talks are set to resume next week, according to Bloomberg. The main sticking point between the two sides? Automation.
LONDON, Dec 30 (Reuters) - Chemicals factories founded or owned by some of Russia's wealthiest men are supplying ingredients to plants that manufacture explosives used by Moscow's military during the war in Ukraine, an analysis of railway and financial data shows.
Billionaire investor Mark Cuban's question to Representative Matt Gaetz, a Florida Republican, on energy costs took off on social media on Saturday.
Florida lawmakers have banned wind turbines off its shores and near the coast, saying the bill is meant to protect wildlife and prevent noise.